SLS
$SLS
SELLAS Life Sciences Group, Inc.
Biotech company developing cancer immunotherapies.
Healthcare$4.76
+0.00 (+0.00%)
Day Range$4.53 - $4.84
Prev Close$4.76
Analyst Rating
Strong Buy
6 Buy / 1 Hold / 0 Sell
Subscribers
1
Tracking this ticker
Next Report
Sun, Apr 19
Weekly updates
Latest Report
SLS: Pipeline Momentum vs Execution Risk
Sellas Life Sciences ($SLS) has seen momentum from AML preclinical data and a Q4 beat, yet negative earnings, high volatility and execution risk keep the case balanced. Upcoming Q1 results and clinical readouts will be key.
Apr 5, 2026